CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.
Rupp LJ, Schumann K, Roybal KT, Gate RE, Ye CJ, Lim WA, Marson A
Sci Rep. 2017 Apr 7;7(1):737. doi: 10.1038/s41598-017-00462-8.
(Link opens in a new window)
PubMed
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.